Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Evaluation of a novel compound, AZD5634, in healthy volunteers and patients with cystic fibrosis

Evaluation of a novel compound, AZD5634, in healthy volunteers and patients with cystic fibrosis

Resource Type

CF Research News

Authors

Cecilia Kristensson, Annika Åstrand, Scott Donaldson, Ron Goldwater, Raolat Abdulai, Naimish Patel, Philip Gardiner, Ulrika Tehler, Anne-Kristina Mercier, Marita Olsson, Eva Ersdal, Jukka Mäenpää, Tobias Bramer, Anna Malmgren, William Bennett,
Christina Keen

References

J Cyst Fibros. 2022 Feb 26;S1569-1993(22)00042-X. doi: 10.1016/j.jcf.2022.02.010.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Clinical Trials [3]
Pulmonology [4]

Keywords

ENaC inhibitors [5]
clinical trials [6]
Mucociliary clearance [7]
Pharmacokinetics [8]

Date

Saturday, February 26, 2022

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [9]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/evaluation-novel-compound-azd5634-healthy-volunteers-and-patients

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00482R1_FINAL_Astrand_210521.pdf [2] https://pubmed.ncbi.nlm.nih.gov/35227647/ [3] https://www.ecfs.eu/research-article-themes/clinical-trials [4] https://www.ecfs.eu/research-article-themes/pulmonology [5] https://www.ecfs.eu/research-article-keywords/enac-inhibitors [6] https://www.ecfs.eu/research-article-keywords/clinical-trials [7] https://www.ecfs.eu/research-article-keywords/mucociliary-clearance [8] https://www.ecfs.eu/research-article-keywords/pharmacokinetics [9] https://www.ecfs.eu/resource-guideline-type/other-guidelines